Overview
Lifesaving Vision
If your child or teenager's condition requires a bone-marrow transplant, you should know that the Fred Hutchinson Transplant program at SCCA was ranked first in outcomes in a four-year study by the National Marrow Donor Program (NMDP) that measured one-year survival rates of patients among 122 transplant centers in the United States. The Hutchinson Center pioneered the use of bone-marrow transplants as a treatment for blood diseases over 40 years ago. Since then thousands of patients with leukemia have come from around the world to receive bone-marrow transplants at SCCA. Bone-marrow transplants have transformed leukemia and related cancers, once thought incurable, into highly treatable diseases with survival rates as high as 80 percent.
During the treatment period for bone-marrow transplantation, your child's treatment will take place at Seattle Children's by a highly trained and knowledgeable medical team that understands the application of research-based therapies and the care needed for pediatric patients undergoing bone-marrow transplantation.